The human guinea pig may soon be extinct. He (it’s usually a ‘he’) has become endangered through the advances of cell culture science, which increasingly close the gap between in vitro testing (the ...

Organ-on-a-chip maker Emulate has launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that helps illustrate how immune cells are activated and ...

Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...

Who will come up with the killer app for drug discovery, the thing that will make finding new medicines faster, cheaper, and less risky? No one has come close to figuring that out, but a group of ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., today announced that Jim Corbett has been appointed as Chief Executive Officer and Martin Madaus, Ph.D., has been appointed Executive Chairman of the company’s ...

Small cellular models of human tissue can help researchers better understand how the body reacts under rare conditions. Now, Emulate’s organ-on-a-chip will help explore one of the rarest of all: how ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc. announced today that it has formed a strategic partnership with F Hoffman La-Roche AG (Roche) that will use Emulate’s Human Emulation System across R&D programs ...

Emulate has raised $82 million in a series E round to help further develop and commercialize its organ-on-a-chip technology. The Boston, MA company has raised a total of $225 million since it was ...

Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...

Bellevue, WA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- EMulate Therapeutics, a pioneering digital therapeutics company, announces the launch of its community funding round ...